Trial Profile
Retrospective study of repository corticotropin injection versus intravenous immunoglobulin (IVIG), or plasmapheresis (PMP) in Multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2019
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary) ; Immunoglobulins
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 07 Nov 2019 Results published in the Mallinckrodt plc media release
- 07 Nov 2019 According to a Mallinckrodt plc media release, data from this study will be published in the journal Neurology and Therapy.
- 26 Oct 2018 New trial record